Tagged with B

Canada Specializing on products adapted to the needs of seniors and long-term care patients, WeedMD is scaling up its production capacity to better meet the needs of this particular patient group while also preparing for the up-coming legalization of cannabis for recreational use. Bruce Dawson-Scully, WeedMD’s CEO and founder, shares his…

India Vinay Sapte, founder and managing director of Maneesh Pharmaceuticals, provides insights into this company’s unique development path. Maneesh was one of the first Indian companies to establish joint ventures in the US and Europe more than ten years ago and today stands as one of the largest India based partners…

Latvia Inese Bolmane, business development manager at Latvian stem cell bank Cilmes Šūnu Banka, explains the basic rationale behind stem cell banking and what differentiates Cilmes Šūnu Banka from the competition. Could you please start by introducing the Cilmes Šūnu Banka? “One positive by-product of increased competition is that our competitors…

Baltics Roland Lepik, cluster head Baltics at Sandoz, discusses the company’s strategy that has allowed it to rank number one in the Estonian market along with the importance of ever-closer collaboration with key stakeholders to enhance the uptake of biosimilars. Roland, prior to joining Sandoz as Cluster Head Baltics you were…

Baltics Janis Biezbardis, chairman and owner of Latvian pharmaceutical wholesaler Farmeko, discusses the evolution of the company’s product portfolio, the receptiveness of the Latvian state to homegrown companies, and Farmeko’s international reach. Could you please start by telling us about the origins of your company? “The Latvian investment board and development…

India Murtaza Khorakiwala, managing director of Wockhardt, discusses the company’s vast international expertise in the manufacturing of pharmaceuticals and biopharmaceutical formulations in their 12 US FDA, UK MHRA and EMA compliant manufacturing facilities in India, as well as the out-licensing of its products into other regions to capture and penetrate new…

Canada Panalpina’s Dimitri Brink speaks about the main highlights of his first two years of tenure in the Canadian affiliate and how he brought the fully closed GDP (good distribution practices) supply chain network to the local operations. He speaks about his intentions of growing the healthcare vertical as well as…

Poland Piotr Steczniewski, president of Profarm PS – a successful wholesale family business – since 2012, shares how the company has managed to thrive over the years through constant adaptation to the market and laws. He discusses how strict distribution regulations have been affecting the industry and ultimately advises the government…

Baltics Andrejs Pantelejevs, head of bureau of the Ministry of Health of Latvia, discusses the importance of channeling the recent EUR 200 million healthcare financing to raising the wages of practitioners, reimbursing expensive innovative medicines in therapeutic areas such as oncology and cardiovascular diseases as well as strengthening e-health. Can you…

India As managing director of India’s fifth largest pharmaceutical company, Zydus Cadila’s Sharvil Patel shares his insights on his impressive internationalization strategy with a special focus on the US where Zydus recently received permission to conduct Phase II clinical studies of Lipaglyn, the first drug to treat patients with nonalcoholic steatohepatitis…

Ecuador José Hernández, general manager of CC Laboratories, takes us through the actions he undertook to convert the family run business into a model of operational efficiency. The company increased its sales by a staggering 39% in 2017 and has doubled its profitability over the course of the last three years…

Canada Frank Baylis, chairman of the board at Baylis shares his views on his motivations for maintaining a lifelong interest in healthcare, the Baylis approach to problem solving, and sharing knowledge between university institutions and industry. Can you explain the founding of Baylis Medical? “Canada is a unique market in that…